Aurora Cannabis (ACB) vs Niagen Bioscience (NAGE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Aurora Cannabis (ACB) has outperformed Niagen Bioscience (NAGE) over the past year, losing 1.2% versus a loss of 73.3%. Over five years, NAGE leads with a -62.5% price change compared with -93.9% for ACB. Aurora Cannabis is the larger company by market cap ($273.5 million vs $145.7 million), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | NAGE |
|---|---|---|
| Share price | $4.16 | $1.84 |
| Market cap | $273.50M | $145.72M |
| 1-day change | -2.35% | -1.60% |
| YTD return | -1.42% | -71.07% |
| 1-year return | -1.19% | -73.26% |
| 5-year return | -93.87% | -62.53% |
| P/E ratio (TTM) | — | 15.33 |
| EPS (TTM) | $-0.19 | $0.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $129.42M |
| Revenue growth (YoY) | — | +29.95% |
| Net income (latest FY) | — | $17.38M |
| Gross margin | — | 64.28% |
| Operating margin | — | 12.58% |
| Net margin | — | 13.43% |
| 52-week high | $6.36 | $7.11 |
| 52-week low | $2.56 | $1.79 |
| Distance from 52-week high | -34.59% | -74.12% |
| Analyst consensus | underperform | strong_buy |
| Avg. price target upside | — | +479.89% |
| Average volume | 1.31M | 522.66K |
| Shares outstanding | 65.74M | 79.20M |
| Employees | 1,028 | 117 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ACB has outperformed NAGE by 72.1 percentage points over the past year.
About Aurora Cannabis
ACB stock →Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Health Care · Medicinal Chemicals and Botanical Products · 1,028 employees
About Niagen Bioscience
NAGE stock →Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.
Health Care · Medicinal Chemicals and Botanical Products · 117 employees
ACB vs NAGE FAQ
Which is bigger, Aurora Cannabis or Niagen Bioscience?
Aurora Cannabis (ACB) is larger, with a market capitalization of $273.50M compared with $145.72M for Niagen Bioscience (NAGE).
Which stock has performed better over the past year, ACB or NAGE?
ACB returned -1.19% over the past 12 months, compared with -73.26% for NAGE (price return, excluding dividends). Past performance does not predict future results.
Are Aurora Cannabis and Niagen Bioscience in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.